SEARCH

SEARCH BY CITATION

References

  • Balosso S., Ravizza T., Aronica E. and Vezzani A. (2013) The dual role of TNF-alpha and its receptors in seizures. Exp. Neurol. 247, 267271.
  • Black J. A., Liu S. and Waxman S. G. (2009) Sodium channel activity modulates multiple functions in microglia. Glia 57, 10721081.
  • Blotnik S., Bergman F. and Bialer M. (1996) Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats. Drug Metab. Dispos. 24, 560564.
  • Catterall W. A. (1999) Molecular properties of brain sodium channels: an important target for anticonvulsant drugs. Adv. Neurol. 79, 441456.
  • Dambach H., Hinkerohe D., Prochnow N., Stienen M. N., Moinfar Z., Haase C. G., Hufnagel A. and Faustmann P. M. (2014) Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation. Epilepsia 55, 184192.
  • De Simoni M. G., Perego C., Ravizza T., Moneta D., Conti M., Marchesi F., De Luigi A., Garattini S. and Vezzani A. (2000) Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci. 12, 26232633.
  • Dube C., Vezzani A., Behrens M., Bartfai T. and Baram T. Z. (2005) Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann. Neurol. 57, 152155.
  • Dutov A. A., Tolpyshev B. A., Petrov A. P. and Gladun V. N. (1986) Use of cavinton in epilepsy. Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova 86, 850855.
  • Fieschi C., Lenzi G. L., Zanette E., Orzi F. and Passero S. (1980) Effects on EEG of the osmotic opening of the blood-brain barrier in rats. Life Sci. 27, 239243.
  • Frank M. G., Barrientos R. M., Thompson B. M., Weber M. D., Watkins L. R. and Maier S. F. (2012) IL-1RA injected intra-cisterna magna confers extended prophylaxis against lipopolysaccharide-induced neuroinflammatory and sickness responses. J. Neuroimmunol. 252, 3339.
  • Galvan E. and Sitges M. (2004) Characterization of the participation of sodium channels on the rise in Na+ induced by 4-aminopyridine (4-AP) in synaptosomes. Neurochem. Res. 29, 347355.
  • Gorter J. A., van Vliet E. A., Aronica E., Breit T., Rauwerda H., Lopes da Silva F. H. and Wadman W. J. (2006) Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J. Neurosci. 26, 1108311110.
  • Graumlich J. F., McLaughlin R. G., Birkhahn D., Shah N., Burk A., Jobe P. C. and Dailey J. W. (2000) Subcutaneous microdialysis in rats correlates with carbamazepine concentrations in plasma and brain. Epilepsy Res. 40, 2532.
  • Haghikia A., Ladage K., Lafenetre P., Haghiki A., Hinkerohe D., Smikalla D., Haase C. G., Dermietzel R. and Faustmann P. M. (2008) Intracellular application of TNF-alpha impairs cell to cell communication via gap junctions in glioma cells. J. Neurooncol. 86, 143152.
  • Heida J. G., Boisse L. and Pittman Q. J. (2004) Lipopolysaccharide-induced febrile convulsions in the rat: short-term sequelae. Epilepsia 45, 13171329.
  • Himmerich H., Bartsch S., Hamer H., Mergl R., Schönherr J., Petersein C., Munzer A., Kirkby K. C., Bauer K. and Sack U. (2013) Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro. J. Psychiatr. Res. 47, 17511759.
  • Hsu H. C., Tang N. Y., Liu C. H. and Hsieh C. L. (2013) Antiepileptic effect of uncaria rhynchophylla and rhynchophylline involved in the initiation of c-jun n-terminal kinase phosphorylation of MAPK signal pathways in acute seizures of kainic acid-treated rats. Evid. Based Complement. Alternat. Med. 2013, 961289.
  • Jeon K. I., Xu X., Aizawa T., Lim J. H., Jono H., Kwon D. S., Abe J., Berk B. C., Li J. D. and Yan C. (2010) Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proc. Natl Acad. Sci. USA 107, 97959800.
  • Löscher W. (2002) Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs 16, 669694.
  • Löscher W., Puskarjov M. and Kaila K. (2013) Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments. Neuropharmacology 69, 6274.
  • Marchi N., Angelov L., Masaryk T. et al. (2007) Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 48, 732742.
  • Marchi N., Fan Q., Ghosh C. et al. (2009) Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol. Dis. 33, 171181.
  • Maroso M., Balosso S., Ravizza T. et al. (2010) Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 16, 413419.
  • Nekrassov V. and Sitges M. (2004) Vinpocetine inhibits the epileptic cortical activity and auditory alterations induced by pentylenetetrazole in the guinea pig in vivo. Epilepsy Res. 60, 6371.
  • Nekrassov V. and Sitges M. (2006) Additive effects of antiepileptic drugs and pentylenetetrazole on hearing. Neurosci. Lett. 406, 276280.
  • Nekrassov V. and Sitges M. (2008) Comparison of acute, chronic and post-treatment effects of carbamazepine and vinpocetine on hearing loss and seizures induced by 4-aminopyridine. Clin. Neurophysiol. 119, 26082614.
  • Pavone A. and Cardile V. (2003) An in vitro study of new antiepileptic drugs and astrocytes. Epilepsia 44, 3439.
  • Plata-Salaman C. R., Ilyin S. E., Turrin N. P., Gayle D., Flynn M. C., Romanovitch A. E., Kelly M. E., Bureau Y., Anisman H. and McIntyre D. C. (2000) Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions. Brain Res. Mol. Brain Res. 75, 248258.
  • Ravizza T. and Vezzani A. (2006) Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience 137, 301308.
  • Ravizza T., Gagliardi B., Noe F., Boer K., Aronica E. and Vezzani A. (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 29, 142160.
  • Reagan-Shaw S., Nihal M. and Ahmad N. (2008) Dose translation from animal to human studies revisited. FASEB J. 22, 659661.
  • Reid A. Y., Galic M. A., Teskey G. C. and Pittman Q. J. (2009) Febrile seizures: current views and investigations. Can. J. Neurol. Sci. 36, 679686.
  • Sinclair D. B. (2003) Prednisone therapy in pediatric epilepsy. Pediatr. Neurol. 28, 194198.
  • Sinha S., Patil S. A., Jayalekshmy V. and Satishchandra P. (2008) Do cytokines have any role in epilepsy? Epilepsy Res. 82, 171176.
  • Sitges M. and Nekrassov V. (2004) Vinpocetine prevents 4-aminopyridine-induced changes in the EEG, the auditory brainstem responses and hearing. Clin. Neurophysiol. 115, 27112717.
  • Sitges M., Galvan E. and Nekrassov V. (2005) Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes. Neurochem. Int. 46, 533540.
  • Sitges M., Chiu L. M. and Nekrassov V. (2006) Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings. Neurochem. Int. 49, 5561.
  • Sitges M., Chiu L. M., Guarneros A. and Nekrassov V. (2007a) Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings. Neuropharmacology 52, 598605.
  • Sitges M., Guarneros A. and Nekrassov V. (2007b) Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: comparison with the Na+ channel-mediated release. Neuropharmacology 53, 854862.
  • Sitges M., Sanchez-Tafolla B. M., Chiu L. M., Aldana B. I. and Guarneros A. (2011) Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs. Epilepsy Res. 96, 257266.
  • Sitges M., Aldana B. I., Gomez C. D. and Nekrassov V. (2012) The antidepressant sertraline prevents the behavioral and EEG changes induced in two animal models of seizures. Epilepsy Behav. 25, 511516.
  • Stienen M. N., Haghikia A., Dambach H. et al. (2011) Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFß1 regulation. Br. J. Pharmacol. 162, 491507.
  • Suda S., Katsura K., Kanamaru T., Saito M. and Katayama Y. (2013) Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation. Eur. J. Pharmacol. 707, 2631.
  • Taylor C. P. and Narasimhan L. S. (1997) Sodium channels and therapy of central nervous system diseases. Adv. Pharmacol. 39, 4798.
  • Turrin N. P., Gayle D., Ilyin S. E., Flynn M. C., Langhans W., Schwartz G. J. and Plata-Salaman C. R. (2001) Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res. Bull. 54, 443453.
  • Vereczkey L., Szentirmay Z. and Szporny L. (1979) Kinetic metabolism of vinpocetine in the rat. Arzneimittelforschung 29, 953956.
  • Verhelst H., Boon P., Buyse G. et al. (2005) Steroids in intractable childhood epilepsy: clinical experience and review of the literature. Seizure 14, 412421.
  • Vezzani A., Friedman A. and Dingledine R. J. (2013) The role of inflammation in epileptogenesis. Neuropharmacology 69, 1624.